Anticipated 0 11 0 11 O
receipt 12 19 12 19 O
of 20 22 20 22 O
a 23 24 23 24 O
rifamycin 25 34 25 34 B-treatment
class 35 40 35 40 I-treatment
( 41 42 41 42 O
excluding 42 51 42 51 O
rifaxamin 52 61 52 61 B-treatment
) 61 62 61 62 O
antibiotic 63 73 63 73 O
from 74 78 74 78 O
Day 79 82 79 82 O
1 83 84 83 84 O
to 85 87 85 87 O
study 88 93 88 93 O
completion 94 104 94 104 O
/ 104 105 104 105 O
discontinuation 105 120 105 120 O

Body 0 4 121 125 B-bmi
mass 5 9 126 130 I-bmi
index 10 15 131 136 I-bmi
greater 16 23 137 144 O
than 24 28 145 149 O
or 29 31 150 152 O
equal 32 37 153 158 O
( 38 39 159 160 O
> 39 40 160 161 O
/= 40 42 161 163 O
) 42 43 163 164 O
18 44 46 165 167 B-lower_bound
to 47 49 168 170 O
less 50 54 171 175 O
than 55 59 176 180 O
or 60 62 181 183 O
equal 63 68 184 189 O
to 69 71 190 192 O
( 72 73 193 194 O
< 73 74 194 195 O
/= 74 76 195 197 O
) 76 77 197 198 O
40 78 80 199 201 B-upper_bound
kg 81 83 202 204 I-upper_bound
/ 83 84 204 205 I-upper_bound
m^2 84 87 205 208 I-upper_bound

Exposure 0 8 209 217 O
to 9 11 218 220 O
any 12 15 221 224 O
biological 16 26 225 235 B-treatment
therapy 27 34 236 243 I-treatment
or 35 37 244 246 O
investigational 38 53 247 262 B-treatment
biological 54 64 263 273 I-treatment
agent 65 70 274 279 I-treatment
within 71 77 280 286 O
90 78 80 287 289 B-upper_bound
days 81 85 290 294 I-upper_bound
prior 86 91 295 300 I-upper_bound
to 92 94 301 303 O
the 95 98 304 307 O
screening 99 108 308 317 O
evaluation 109 119 318 328 O
or 120 122 329 331 O
have 123 127 332 336 O
received 128 136 337 345 O
any 137 140 346 349 O
other 141 146 350 355 O
investigational 147 162 356 371 B-treatment
treatment 163 172 372 381 I-treatment
30 173 175 382 384 O
days 176 180 385 389 O
prior 181 186 390 395 O
to 187 189 396 398 O
the 190 193 399 402 O
screening 194 203 403 412 O
evaluation 204 214 413 423 O

History 0 7 424 431 O
or 8 10 432 434 O
presence 11 19 435 443 O
of 20 22 444 446 O
an 23 25 447 449 O
abnormal 26 34 450 458 O
electrocardiogram 35 52 459 476 B-clinical_variable
( 53 54 477 478 I-clinical_variable
ECG 54 57 478 481 I-clinical_variable
) 57 58 481 482 I-clinical_variable

In 0 2 483 485 O
the 3 6 486 489 O
investigator 7 19 490 502 O
's 19 21 502 504 O
judgment 22 30 505 513 O
, 30 31 513 514 O
an 32 34 515 517 O
expected 35 43 518 526 O
treatment 44 53 527 536 O
duration 54 62 537 545 O
for 63 66 546 549 O
S. 67 69 550 552 B-chronic_disease
aureus 70 76 553 559 I-chronic_disease
intravenous 77 88 560 571 I-chronic_disease
infection 89 98 572 581 I-chronic_disease
with 99 103 582 586 O
anti 104 108 587 591 B-treatment
- 108 109 591 592 I-treatment
staphylococcal 109 123 592 606 I-treatment
SOC 124 127 607 610 I-treatment
antibiotics 128 139 611 622 I-treatment
> 140 141 623 624 O
/= 141 143 624 626 O
4 144 145 627 628 B-lower_bound
weeks 146 151 629 634 I-lower_bound

In 0 2 635 637 O
the 3 6 638 641 O
investigator 7 19 642 654 O
's 19 21 654 656 O
judgment 22 30 657 665 O
, 30 31 665 666 O
the 32 35 667 670 O
need 36 40 671 675 O
for 41 44 676 679 O
emergent 45 53 680 688 O
valve 54 59 689 694 B-treatment
surgery 60 67 695 702 I-treatment
at 68 70 703 705 O
the 71 74 706 709 O
time 75 79 710 714 O
of 80 82 715 717 O
randomization 83 96 718 731 O
or 97 99 732 734 O
a 100 101 735 736 O
high 102 106 737 741 O
likelihood 107 117 742 752 O
of 118 120 753 755 O
cardiac 121 128 756 763 B-treatment
surgery 129 136 764 771 I-treatment
within 137 143 772 778 O
3 144 145 779 780 B-upper_bound
days 146 150 781 785 I-upper_bound
after 151 156 786 791 O
randomization 157 170 792 805 O

Participants 0 12 806 818 O
with 13 17 819 823 O
significant 18 29 824 835 O
immune 30 36 836 842 B-treatment
suppression 37 48 843 854 I-treatment

The 0 3 855 858 O
presence 4 12 859 867 O
of 13 15 868 870 O
an 16 18 871 873 O
intravascular 19 32 874 887 O
catheter 33 41 888 896 O
that 42 46 897 901 O
is 47 49 902 904 O
not 50 53 905 908 O
planned 54 61 909 916 O
to 62 64 917 919 O
be 65 67 920 922 O
removed 68 75 923 930 O
within 76 82 931 937 O
96 83 85 938 940 B-upper_bound
hours 86 91 941 946 I-upper_bound
of 92 94 947 949 O
study 95 100 950 955 O
randomization 101 114 956 969 O

participants 0 12 970 982 O
with 13 17 983 987 O
cirrhosis 18 27 988 997 B-chronic_disease
, 27 28 997 998 O
a 29 30 999 1000 O
Child 31 36 1001 1006 B-clinical_variable
- 36 37 1006 1007 I-clinical_variable
Pugh 37 41 1007 1011 I-clinical_variable
Score 42 47 1012 1017 I-clinical_variable
of 48 50 1018 1020 I-clinical_variable
Class 51 56 1021 1026 I-clinical_variable
B 57 58 1027 1028 I-clinical_variable
or 59 61 1029 1031 I-clinical_variable
C 62 63 1032 1033 I-clinical_variable

